Graham David Mullis founded Optivue LLP. Currently, he is Chief Executive Officer & Executive Director at Novacyt SAS.
He is also on the board of Microgen Bioproducts Ltd., Primerdesign Ltd. and Novacyt UK Holdings Ltd.
In his past career Mr. Mullis held the position of President & Managing Director at Clearlab SG Pte Ltd., Principal at Optivue LLP, Principal at R.P. Scherer Ltd., Chief Executive Officer & Director at Lab 21 Ltd., Vice President-Operations of Biocompatibles Eyecare, Inc. and President-International Operations at 1-800 Contacts, Inc.
He received an undergraduate degree from The University of Southampton, an MBA from the University of Warwick and an MBA from Warwick Business School.